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Abstract 
Objectives: The aim of this study was to estimate the prevalence of subclinical small 
joint synovitis detected by ultrasonography in patients with axial SpA, and to evaluate 
their relevance in terms of function or and disease activity.  
Methods: Forty axial SpA patients, 40 RA and 20 healthy subjects were evaluated  
by ultrasonography, using a reproducible semi-quantitative score by B-mode and 
Doppler, for synovitis, while disease activity and function were assessed using 
validated instruments (DAS28, BASDAI, BASFI, m-SACRAH and HAQ).  
Results: Median B-mode score were respectively 8.2 for axial SpA, 11.5 for RA and 
6.0 for healthy subjects, corresponding to a prevalence of clinical significant synovitis 
of respectively 37.5%, 60% and 11% for a level of significance at > 8 chosen to 
classify as active > 75% of RA patient with DAS28 >2.6 and < 10% of controls. 
Addtionally, Doppler was positive in 8% of SpA, 30 % of RA and none of the healthy 
subjects. Echographic synovitis correlated with disease activity (DAS28) and function 
(HAQ, mSACRAH) in RA patients, but no correlation were found for SpA patients 
with disease activity (BASDAI) or function (BASFI, HAQ, mSACRAH). Cases of 
synovitis using classification by Doppler positivity were insufficient to allow any 
statistical analysis. 
Conclusions: B-mode ultrasonographic evaluation can demonstrate subclinical 
synovitis in almost 40% of SpA patients, but they do not appear to correlate with 
disease activity or function on the contrary to what is observed in RA patients, 
representing potentially different processes 
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Introduction 
The definition of new classification criteria for axial spondyloarthropathies (SpA) [1] 
has allowed us to diagnose them much earlier than the previous cases of established 
ankylosing spondylitis (AS), as defined by the modified New York criteria [2]. With 
those new criteria, there is also the recognition that the disease is much more 
prevalent than initial believed, affecting probably more than 1% of the population 
[3,4]. We also observe a change in the recognized features of the disease, with much 
more female patients [5], and the appreciation that severe ankylosis is not at all 
mandatory [6].  
If oligoarthritis is a classical feature of axial SpA [7,8], affecting about 30% of 
patients, small joints peripheral arthritis is not a typical feature of SpA, but for 
psoriatic arthritis[9]. However, with this shift in population, it appears to us that 
perhaps more patients, especially women, complain of pain from small peripheral 
joints in the absence of obvious clinical synovitis. Musculoskeletal ultrasound (US) 
and MRI imaging have convincingly demonstrate the limitation of clinical examination 
at detecting small joint synovitis in rheumatoid arthritis (RA) [10-13], as well as the 
importance of those subclinical synovitis in term of disease activity and treatment 
strategies [13-15]. 
The present study was undertook to estimate the prevalence of subclinical small joint 
synovitis detected by echography in patients suffering from axial SpA, without 
obvious peripheral disease, and to evaluate if the detected synovitis were relevant in 
terms of function, a fact which could influence the view on disease management and 
strategies, or in terms of disease activity, as a simple objective mean to quantify 
disease activity would be useful in this disease.  
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Patients and methods 
Forty consecutive adult patients with axial SpA, as well as 40 consecutive RA 
patients were recruited from the outpatient clinic of our Department of Rheumatology. 
All SpA patients had to fulfill the new ASAS classification criteria for axial disease [1]. 
SpA patients were included regardless of treatment or disease activity, without any 
exclusion but for the presence or history of documented oligoarthritis. Similarly, RA 
patients were included regardless of treatment or disease activity, but had to fulfill the 
ACR 1987 criteria [16] and had to have an ACR functional class of ≤ 2 [17]. 
Furthermore, 20 healthy subjects without any known rheumatologic diseases were 
recruited as controls from patient’s relatives or within our department.  
All patients and healthy subjects underwent clinical and ultrasonographic evaluation 
in a standardized order the same day. Participants were initially asked to complete 
the following self-evaluation assessments for disease activity (BASDAI) [18], function 
(BASFI) [19], hand function (m-SACRAH) [20] and quality of life (HAQ) [21], 
regardless of the diagnosis. Evaluation was followed by a clinical (28-joint count) and 
US assessment by two independent investigators (CM and PZ) blinded to patient’s 
evaluations, but not diagnosis. 
All US assessments were performed using a Philips HD-11 US machine with a 
15mHz linear probe using the Swiss Sonography in Arthritis and Rheumatism 
(SONAR) score, a reproducible semi-quantitative score for synovitis in RA using 
OMERACT criteria (PZ, manuscript in preparation).  The score includes B-mode and 
Doppler evaluation of metacarpophalangeal and proximal interphalangeal joints 2 to 
5, wrists, elbows and knees (22 joints). Each joint is graded from 0 (normal) to 3 for 
synovitis using reference image (fig 1) with a maximum score of 66 points. In 
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addition, each joint is separately evaluated for Doppler abnormalities (positive or 
negative) (fig 1).  Final score was determined by consensus of the two 
ultrasonographers. In short, patients were asked to adopt the most appropriate 
position that produced an optimal sonographic scan of the various joints. Gel was 
applied to the skin to provide an acoustic interface and US examination was carried 
out first in grey-scale modality, with additional Doppler evaluation.  
All procedures were reviewed by the local ethic committee (Commission cantonale 
d’éthique de la recherche sur l’être humain, Lausanne, Switzerland) and a signed 
informed consent was obtained before any evaluation. 
 
Statistical analysis 
Data analysis was performed using Stata 11.0 (Stata Corporation, College Station, 
Texas, USA). The significance level was set at 0.05. For categorical variables, 
between groups comparisons were computed using a Fisher’s exact test. Numerical 
variables were analyzed using ANOVA followed by Tukey HSD tests, or Kruskal-
Wallis rank test with Mann-Whitney tests for post-hoc comparisons, where 
appropriate. To account for multiple comparisons, a Keppel’s modified Bonferroni 
correction [22] was used (α = df  0.05/c, where α, df and c are respectively 
adjusted p value, degrees of freedom and number of comparisons). Accordingly, the 
significance thresholds of post-hoc analyzes were set at P<0.033 and P<0.017 when 
the number of modalities of the independent variable was respectively 3 and 6. 
Correlations of B-mode score with other scores were analyzed using Spearman’s 
rho. Within RA patients, disease-related scores in Doppler positive and negative 
patients were compared using a Mann-Whitney test. 
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Results 
Patients demographics  
Finally, 40 consecutive adult patients with axial SpA and 40 RA patients were 
evaluated, as well as 18 healthy subjects. The main clinical and demographic 
features are shown in table 1. Groups were similar in term of gender and age. 
Disease activity was low for our RA group, with a median DAS28 within the LDAS 
range, an observation reflecting a treated population. For axial SpA, disease activity 
appeared seemingly higher, with a median BASDAI of 6.4. However, sedimentation 
rate and CRP were low and similar between RA and SpA patients. Finally, if swollen 
and tender joints counts were low as expected in this population, there was a 
statistically significant difference between both groups and the controls, as well as 
between RA and SpA. Similarly, the HAQ and m-SACRAH scores were significantly 
higher in SpA and RA than in the healthy subjects, but no significantly different 
between the two diseases.  
Echographic synovitis (table 1 and fig 2). 
As echographic joint evaluation can demonstrate positive score by B-mode even in 
normal healthy subjects, we had to set a level of clinical significance for echographic 
synovitis to calculate a prevalence of echographic synovitis in our population. The 
level of significance for B-mode was chosen as such as to classify as significant 
< 10% of controls and > 75% of the active RA (DAS28 > 2.6), while any Doppler 
positive joint was considered positive.  
Mean B-mode score was 11.5 (± 7.7) for RA, 8.2 (± 4.2) for axial SpA and 6.0 (± 2.1) 
for healthy subjects without known joint diseases, with a calculated score for the level 
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of significance at > 8. If axial SpA did not differ, as a group from normal subjects in 
this treated population, 37,5% of SpA patients had significant echographic synovitis 
as defined by the level of significance, as compared to 60 % of the RA population. In 
contrast, Doppler was positive in only 8% of axial SpA (3 patients) and 30 % of RA 
(12 patients), but none of the healthy subjects.  
Disease activity, function and correlation with echographic synovitis 
If presence of echographic synovitis evaluated by B-mode correlated with disease 
activity in terms of DAS28 in RA patients, no correlation was found in SpA patients 
with disease activity as evaluated with the BASDAI (table 2), nor with the third item of 
the BASDAI evaluating peripheral symptoms. Likewise, swollen and tender joints 
counts were highly correlated to the B-mode scores in RA patients, while only 
swollen joints counts showed a trend in axial SpA, not reaching statistical 
significance. Interestingly, in these mild diseases, CRP and sedimentation rate did 
not correlate with synovitis as detected by B-mode (table 2). 
Likewise, if HAQ and m-SACRAH scores were highly correlated to B-mode score in 
RA, no significant correlation was found in SpA. BASFI scores did not display either 
any correlation with ultrasonographic synovitis by B-mode score in axial SpA. 
However, when RA patients were asked to fill the same self-evaluation assessment, 
their scores were highly correlated with the B-mode score (table 2). 
 
Small joint synovitis in axial SpA 
Page 9 / 23 
Discussion 
Small joints peripheral arthritis is the hallmark of RA [16], while oligoarthritis is a 
classical and well recognized peripheral feature of axial SpA [7,8]. It is however fairly 
uncommon, affecting about 30% of patients at some point of the disease. In recent 
years, the concept of subclinical synovitis has been well established in RA [10,11], 
and its importance is underlined by the numerous studies evaluating the role of US in 
our current treat-to-target strategy [15,23]. If small joint synovitis is not a recognized 
feature of SpA, there is a current change in our appreciation and view on this disease 
with less stress put on ankylosis and radiologic changes. With this shift, we see more 
women with more general complaints, including pain in hands and small peripheral 
joints, which could potentially be related to undiagnosed subclinical synovitis. To our 
knowledge, no formal evaluation of subclinical synovitis had been undertaken in this 
population, and the present study was set up to estimate the prevalence of such 
subclinical small joint synovitis detected by echography in patients suffering from 
axial SpA, without obvious peripheral disease, and to evaluate their clinical 
significance.  
The first hurdle in all echographic joint evaluation is the definition of significance. As 
the literature has clearly demonstrated the clinical significance of echographic 
synovitis in RA, we set our level of significance using RA patients and healthy 
subjects to define a prevalence of clinically significant synovitis, while avoiding as 
much as possible any overestimation. Using this threshold, subclinical synovitis was 
demonstrated by B-mode US in almost 40% of axial SpA and 60% of RA patients. 
Thus, small joints synovitis detected by ultrasonography using a similar protocol as 
for RA appears fairly common in axial SpA and much more prevalent than usually 
regarded. However, the clinical significance of such observation remains doubtful. If 
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in RA patients, we observed a clear correlation between US synovitis and disease 
activity on one hand, and functional scores on the other, an observation confirming a 
larger study using SONAR score in the swiss RA cohort (SCQM) on more than 500 
patients (PZ, manuscript in preparation), we did not find any correlation in axial SpA 
between B-mode synovitis and either disease activity or functional scores. If US 
synovitis correlated very well with disease activity (DAS28) or the swollen and tender 
joint counts in RA, we were unable to demonstrate any correlation in our SpA 
population with disease activity using the BASDAI. We did not find correlation either 
with the third item of the BASDAI evaluating specifically peripheral symptoms 
(BASDAI3: “How would you describe the overall level of pain/swelling in joints other 
than neck, back or hips you have had?”). Interestingly, we did find a correlation when 
RA patients where asked the same question, pointing toward a different meaning of 
the observed US changes.  
Another important question was to know if the observed synovitis did correlated with 
function or quality of life. US synovitis seems to correlate very well in RA patients to 
function and quality of life (HAQ), and more specifically to the hand function using the 
m-SACRAH score, underlining its clinical relevance in this disease, especially in low 
disease activity state. Nevertheless, we were unable again to demonstrate any 
correlation between the observed US synovitis and function or quality of life in our 
axial SpA population, using either the BASFI, the HAQ or the m-SACRAH. 
From our observation, it appears that if subclinical synovitis can be demonstrated in 
almost 40% of axial SpA using a similar protocol than for RA patients, their clinical 
significance is totally different in both diseases, with little significance in axial SpA; 
and that these images probably represent different histological and 
pathophysiological processes.  
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It is possible that Doppler positivity would be a better mean to define clinical 
significant synovitis in axial SpA. However, while 30% of RA were positive using this 
criterion, only 3 of our patients with axial SpA (8%) were positive, preventing any 
statistical evaluation. Nevertheless, for RA at least, we observed the same 
correlation between clinical significant synovitis defined by Doppler with disease 
activity and function than observed with the B-mode evaluation (table 3), and it 
appears unlikely that both mode of evaluation represent totally different pathological 
processes. 
There are surely limitations to our study. Evaluators were not blinded to diagnosis, as 
most patients and controls were known to them. Similarly, clinical examinations were 
performed by the same evaluators. However, the relation between clinical and 
ultrasonographic synovitis is similar between the three groups, speaking against a 
true bias. Mean to assess disease activity are also very different. In RA, synovitis is 
part of the evaluation and finding a correlation appears obvious, while the BASDAI 
has no direct correlation to small joint disease. However, disease activity was much 
higher in the axial SpA (median BASDAI 6.4) than in RA (median DAS28 3.0), a 
difference that would favors the probability to demonstrate a correlation in the group 
with the highest activity. In spite of that, we were unable to demonstrate any 
correlation in SpA, on the contrary to the RA despite a very low median disease 
activity. Furthermore, restricting the evaluation of disease activity only to peripheral 
symptoms in SpA (BASDAI3) was not more conclusive, while significant again in RA. 
In addition, if we did not use the ASDAS index to evaluate disease activity [24], it is 
unlikely that it would yield significant results as it is based mainly on the BASDAI plus 
the CRP, an additional parameter that did not correlate either with the observed 
synovitis. 
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Globally, the function and quality of life data appear more solid as we used generic 
questionnaire (HAQ and m-SACRAH), less dependent on the population studied. 
Finally, there is always the question of the size of the studied population, but it seems 
to us that groups of 40 are reasonable, a fact underlined by the demonstration of very 
significant correlation in the RA population. If a much larger sample could perhaps 
yield statistically significant results, it is unlikely they would drastically change the 
clinical implication of our observation. 
In conclusion, if musculoskeletal ultrasound allows to readily demonstrate subclinical 
synovitis in a substantial number of axial SpA, their clinical significance remains 
dubious and debatable. In an era where US gains more popularity in the evaluation 
of SpA, in particular enthesitis [25-27], we should be cautious not to overestimate the 
clinical significance of all imaging observations.  
 
Key messages 
• B-mode ultrasonographic evaluation demonstrates subclinical synovitis in 
almost 40% of SpA patients 
• But ultrasonographic subclinical synovitis do not correlate with disease activity 
or function in SpA. 
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Figure legends: 
 
Figure 1: reference images for the SONAR grade 1 to 3 (grade 0 = normal) and 
Doppler positivity (http://sonar.irheuma.com). 
 
Figure 2: Individual B-mode scores for synovitis in SpA, RA and healthy controls 
using the SONAR protocol. (Grey zone = below level of significance). 
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Figure 2 
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Table 2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: Correlation between disease and functional scores and clinically significant 
synovitis detected by B mode US. 
 
 
 
 
 
 
 
 
 
 SpA (n=40) RA (n=40) 
 ρ  P § ρ  P § 
DAS28   0.57  (<0.001)   
SJC 0.31 0.055 0.54 (<0.001)   
TJC 0.02 0.917 0.44 0.004 
CRP 0.00 0.994 0.29 0.077 
ESR -0.36 0.061 -0.03 0.858 
BASDAI -0.12  (0.449)   
BASDAI3 0.01 (0.952) 0.34 (0.040) 
HAQ -0.09  (0.574) 0.37  (0.021) 
BASFI -0.18  (0.280)   
m-SACRAH -0.05  (0.754) 0.52 (0.001) 
SpA = axial spondyloarthritis;  RA = rheumatoid arthritis; 
§ Spearman’s rho analysis 
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Table 3 
 Doppler + 
(n=12) 
Doppler - 
(n=28) 
P § 
DAS28 3.6 (1.7) 2.7 (1.4) 0.053 
SJC 3.0 (3.0) 0.0 (1.5) 0.002 
TJC 5.0 (3.5) 2.0 (5.5) 0.143 
CRP 4.0 (5.0) 2.0 (1.0) 0.038 
ESR 22.0 (25.0) 10.0 (9.0) 0.032 
HAQ 1.2 (1.6) 0.8 (1.4) 0.141 
m-SACRAH 50.0 (37.3) 18.3 (38.4) 0.027 
Values expressed as median (interquartile range). § Mann-Whitney 
test 
 
Legend: Disease-related scores in Doppler + and Doppler - RA patients 
 
